Clinical Trials Directory

Trials / Completed

CompletedNCT01517932

Effects of Dexmedetomidine on Stress Response and Postoperative Analgesia

Effects of Dexmedetomidine on Stress Response and Postoperative Analgesia in Patients Undergoing Thoracotomy During Anesthesia Recovery Period

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Fang Luo · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Dexmedetomidine is a highly selective α2 adrenoreceptor agonist approved by the US FDA for short-term postoperative sedation and analgesia.It can also reduce the stress response without respiratory depression. In this prospective, randomized, double-blind, placebo-controlled study,we gave dexmedetomidine or saline placebo 1h before operations were over and assessed the effects of dexmedetomidine on stress response and postoperative analgesia in patients undergoing thoracotomy during anesthesia recovery period.

Detailed description

Dexmedetomidine can significantly reduce the emergence agitation and postoperative pain in patients who received chest surgery

Conditions

Interventions

TypeNameDescription
DRUGdexmedetomidineIn this arm,midazolam(0.03-0.05mg/kg), propofol(1.5-2.5mg/kg),sufentanil(0.6-0.82μg/kg )and rocuronium(0.8-1.0mg/kg) were used in anesthesia induction. Anaesthesia was maintained with propofol(4-6mg kg-1h-1),remifentanil (0.1-0.2 μg kg-1 min-1)and sevoflurane(1%).Propofol was titrated to maintain intraoperative Narcotrend values between 20 and 46. Patients in this arm received dexmedetomidine 0.2μg/kg i.v. during 10 minutes 1 hour before the end of surgery
DRUGsaline placeboIn this arm,midazolam(0.03-0.05mg/kg), propofol(1.5-2.5mg/kg),sufentanil(0.6-0.82μg/kg )and rocuronium(0.8-1.0mg/kg) were used in anesthesia induction. Anaesthesia was maintained with propofol(4-6mg kg-1h-1),remifentanil (0.1-0.2 μg kg-1 min-1)and sevoflurane(1%).Propofol was titrated to maintain intraoperative Narcotrend values between 20 and 46. Patients in this arm received saline placebo of the same volume i.v. during 10 minutes 1 hour before the end of surgery

Timeline

Start date
2011-06-01
Primary completion
2011-12-01
Completion
2011-12-01
First posted
2012-01-25
Last updated
2013-03-20

Source: ClinicalTrials.gov record NCT01517932. Inclusion in this directory is not an endorsement.